ADA 2017

In part 5 of this Exclusive Interview, Dr. Emily Seto talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the development of mobile health technology.

In part 1 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, California about his work targeting PCSK9 with RNA interference to see how that impacts on lipids and clinical outcomes.

Aaron Kowalski, PhD is the Chief Mission Officer and Vice President of Research at JDRF. He was appointed the JDRF's first Chief Mission officer in December 2014 and serves as a key link between JDRF and the broad diabetes community.

Transcript: Dr. Aaron Kowalski on the meaning of his role as Chief Mission Officer of JDRF, and the work being funded to advance the cause of curing type 1 diabetes one day, as well as toward improving the quality of life for diabetes patients today.

In this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the meaning of his role as Chief Mission Officer and the work being funded to not only advance the cause of curing type 1 diabetes one day in the unknown future, but the work toward improving the quality of life for these people today.

In part 2 of this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the personal impact of diabetes on his own life and defining what a diabetes cure could mean to different people.

In part 1 of this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his role at the JDRF and the studies getting their support.

In part 3 of this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about exciting research applicable to health care professionals.

In part 4, the conclusion of this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his ideal A1C and the #1 benefit of the hybrid closed loop system.

Dr. Carla Greenbaum is the Director of the Diabetes Research Program at Benaroya Research Institute at Virginia Mason in Seattle, WA.